ZA9610533B - Processes and intermediates for preparing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methylpiperidine. - Google Patents

Processes and intermediates for preparing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methylpiperidine.

Info

Publication number
ZA9610533B
ZA9610533B ZA9610533A ZA9610533A ZA9610533B ZA 9610533 B ZA9610533 B ZA 9610533B ZA 9610533 A ZA9610533 A ZA 9610533A ZA 9610533 A ZA9610533 A ZA 9610533A ZA 9610533 B ZA9610533 B ZA 9610533B
Authority
ZA
South Africa
Prior art keywords
indanon
methylpiperidine
dimethoxy
intermediates
benzyl
Prior art date
Application number
ZA9610533A
Other languages
English (en)
Inventor
Keith M Devries
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA9610533B publication Critical patent/ZA9610533B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9610533A 1995-12-15 1996-12-13 Processes and intermediates for preparing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methylpiperidine. ZA9610533B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
ZA9610533B true ZA9610533B (en) 1998-06-15

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610533A ZA9610533B (en) 1995-12-15 1996-12-13 Processes and intermediates for preparing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methylpiperidine.

Country Status (33)

Country Link
EP (1) EP0883607A1 (fr)
JP (1) JP3066083B2 (fr)
KR (1) KR20000064387A (fr)
AP (1) AP708A (fr)
AR (1) AR004368A1 (fr)
AU (1) AU716462B2 (fr)
BG (1) BG102525A (fr)
BR (1) BR9612018A (fr)
CA (1) CA2237647A1 (fr)
CO (1) CO4750831A1 (fr)
CZ (1) CZ180898A3 (fr)
DZ (1) DZ2141A1 (fr)
GT (1) GT199600092A (fr)
HN (1) HN1996000065A (fr)
HR (1) HRP960592A2 (fr)
HU (1) HUP9904275A3 (fr)
IL (3) IL136420A0 (fr)
IS (1) IS4752A (fr)
MA (1) MA24032A1 (fr)
NO (1) NO982712L (fr)
NZ (1) NZ318843A (fr)
OA (1) OA10694A (fr)
PE (1) PE25698A1 (fr)
PL (1) PL197306B1 (fr)
RO (1) RO121382B1 (fr)
RU (1) RU2160731C2 (fr)
SK (1) SK75498A3 (fr)
TN (1) TNSN96153A1 (fr)
TW (1) TW414787B (fr)
UY (1) UY24401A1 (fr)
WO (1) WO1997022584A1 (fr)
YU (1) YU49486B (fr)
ZA (1) ZA9610533B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6252081B1 (en) 1998-01-16 2001-06-26 Eisai Co., Ltd. Process for production of donepezil derivative
IL125809A (en) * 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for making Donafzil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004099142A1 (fr) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Sel de bromhydrate de benzyl-piperidylmethyl-indanone et ses polymorphes
WO2005003092A1 (fr) 2003-07-01 2005-01-13 Hetero Drugs Limited Preparation d'intermediaires pour inhibiteurs de l'acetyl cholinesterase
CN1280273C (zh) * 2003-11-05 2006-10-18 天津和美生物技术有限公司 合成多奈哌齐及其衍生物的方法
KR20070083679A (ko) 2004-09-29 2007-08-24 케마지스 리미티드 약학적으로 순수한 비정질 도네페닐 염산염의 제조를 위한정제된 도네페질 말레산염의 용도
CN100436416C (zh) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 盐酸多奈哌齐合成工艺
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (es) 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar donepezilo
KR20080085195A (ko) * 2006-01-04 2008-09-23 씨아이피엘에이 엘티디. 도네페질의 제조방법 및 중간체
US8247563B2 (en) 2006-12-11 2012-08-21 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
WO2013078608A1 (fr) 2011-11-29 2013-06-06 Ziqiang Gu Pamoate de donepezil et ses procédés de fabrication et d'utilisation
ES2888074T3 (es) 2013-08-16 2021-12-30 Univ Maastricht Tratamiento del deterioro cognitivo con inhibidor de PDE4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
FR2642069B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
DE4439822A1 (de) * 1994-11-08 1996-08-29 Bayer Ag Verfahren zur Herstellung von Benzyl-piperidylmethyl-indanonen

Also Published As

Publication number Publication date
AP708A (en) 1998-12-04
IL136421A0 (en) 2001-06-14
CO4750831A1 (es) 1999-03-31
IS4752A (is) 1998-05-22
NO982712D0 (no) 1998-06-12
NO982712L (no) 1998-06-12
AP9600892A0 (en) 1997-01-31
HUP9904275A3 (en) 2001-05-28
HRP960592A2 (en) 1998-06-30
CZ180898A3 (cs) 1999-05-12
YU66096A (en) 1999-11-22
UY24401A1 (es) 1997-06-09
YU49486B (sh) 2006-08-17
NZ318843A (en) 2000-01-28
CA2237647A1 (fr) 1997-06-26
HUP9904275A2 (hu) 2000-05-28
EP0883607A1 (fr) 1998-12-16
DZ2141A1 (fr) 2002-07-23
TW414787B (en) 2000-12-11
KR20000064387A (ko) 2000-11-06
AU7092596A (en) 1997-07-14
SK75498A3 (en) 1999-08-06
GT199600092A (es) 1998-05-12
AU716462B2 (en) 2000-02-24
OA10694A (en) 2001-05-04
AR004368A1 (es) 1998-11-04
JP3066083B2 (ja) 2000-07-17
PE25698A1 (es) 1998-05-21
RO121382B1 (ro) 2007-04-30
MX9804820A (es) 1998-10-31
PL327512A1 (en) 1998-12-21
BG102525A (en) 1999-05-31
RU2160731C2 (ru) 2000-12-20
MA24032A1 (fr) 1997-07-01
BR9612018A (pt) 1999-02-17
PL197306B1 (pl) 2008-03-31
TNSN96153A1 (fr) 2005-03-15
JPH11500756A (ja) 1999-01-19
WO1997022584A1 (fr) 1997-06-26
HN1996000065A (es) 1997-06-26
IL136420A0 (en) 2001-06-14
IL124452A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
ZA9610533B (en) Processes and intermediates for preparing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methylpiperidine.
CA2186260A1 (fr) Composition contenant de la morphine, du polypyrrolidone et un polyalyleneoxyde
AU3635197A (en) Flourine-containing 1,4 disubstituted piperidine derivatives
HUP0003141A3 (en) 4-phenylpiperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
ZA929011B (en) Novel N-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives.
IL124642A0 (en) N-acyl-2- substituted-4- (benzimidazolyl- or imidazopyridinyl-substituted residues)- piperidines as tachykinin antagonists
HUP9903987A3 (en) N-acyl-2-substituted -4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonosts
HU9600624D0 (en) Piperidine derivatives, process for producing them and their pharmaceutical use
ZA973301B (en) Piperidines and pyrrolidines.
CA2291170A1 (fr) Procedes et intermediaires permettant de dissoudre des stereoisomeres de piperidyl acetamide
EP0714890A3 (fr) Procédé pour la préparation de la 4-amino-2,2,6,6-tétraméthyle piperidine
EP0657438A3 (fr) Procédé pour la préparation d'alkylesulfinylbenzamides et de 1,2-benzoisothiazol-3-ones.
GB9510221D0 (en) Self-crosslinking composition,a product obtained from the composition,and method for manufacturing the product
AU7578496A (en) Azetidine, pyrrolidine and piperidine derivatives
EP1316549A4 (fr) 1-benzyl-4-[(5,6-methoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine
ZA971999B (en) Disubstituted glutarimide, method for its preparation and its use.
HU9700125D0 (en) (1h-indol-4-yl)-piperidine or tetrahydropyridine ethylamines and ethyl carboxamides
HUP0001185A3 (en) 1-phenylalkyl-1,2,3,6-tetrahydropyridines, process for producing them and pharmaceutical compositions containing them
ZA942256B (en) 1,2,5,6-tetrahydropyridine derivative process for preparing it and its applications in therapy
GR3031513T3 (en) 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof
HUP0002895A3 (en) 3-azabicyclo[3.1.0]hexanes, method for producing the same, and their use
AU7319196A (en) Azetidine, pyrrolidine and piperidine derivatives
ZA97524B (en) Single isomer methylphenidate and resolution process.
SI0837848T1 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity